We are live on ! Find out more
CVS icon

CVS Health

1,130 hedge funds and large institutions have $58.3B invested in CVS Health in 2013 Q3 according to their latest regulatory filings, with 86 funds opening new positions, 440 increasing their positions, 470 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 50

2% more funds holding

Funds holding: 1,1071,130 (+23)

2% less capital invested

Capital invested by funds: $59.6B → $58.3B (-$1.33B)

6% less repeat investments, than reductions

Existing positions increased: 440 | Existing positions reduced: 470

1.62% less ownership

Funds ownership: 84.59%82.97% (-1.6%)

18% less call options, than puts

Call options by funds: $227M | Put options by funds: $276M

23% less funds holding in top 10

Funds holding in top 10: 10883 (-25)

Holders
1,130
Holders Change
+23
Holders Change %
+2.08%
% of All Funds
36.63%
Holding in Top 10
83
Holding in Top 10 Change
-25
Holding in Top 10 Change %
-23.15%
% of All Funds
2.69%
New
86
Increased
440
Reduced
470
Closed
50
Calls
$227M
Puts
$276M
Net Calls
-$48.8M
Net Calls Change
-$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
WT
376
Wilmington Trust
Delaware
$8.29M +$285K +4,775 +3%
ECM
377
Ensemble Capital Management
California
$8.24M -$113K -1,890 -1%
KFS
378
Kurt F. Somerville
$8.11M +$40.5K +680 +0.5%
CW
379
Cabot-Wellington
Massachusetts
$8.07M +$122K +2,050 +1%
CCIA
380
Campbell & Co Investment Adviser
Maryland
$7.96M +$8.36M +140,284 New
WAM
381
Wallington Asset Management
Indiana
$7.94M +$141K +2,370 +2%
Natixis Advisors
382
Natixis Advisors
Massachusetts
$7.9M +$202K +3,392 +2%
LBC
383
Lowe Brockenbrough & Co
Virginia
$7.88M +$20K +336 +0.2%
MAM
384
Mastrapasqua Asset Management
Tennessee
$7.78M +$28.8K +484 +0.4%
SM
385
Stratton Management
Pennsylvania
$7.77M +$650K +10,905 +9%
HCM
386
Howland Capital Management
Massachusetts
$7.74M +$282K +4,732 +4%
LAM
387
Lingohr Asset Management
Germany
$7.72M +$2.66M +44,600 +49%
VAM
388
Visium Asset Management
New York
$7.63M +$1.94M +32,604 +32%
MOACM
389
Mutual of America Capital Management
New York
$7.58M +$516K +8,660 +7%
GLA
390
Great Lakes Advisors
Illinois
$7.57M -$155K -2,593 -2%
SSA
391
South Street Advisors
New York
$7.56M +$180K +3,020 +2%
HFS
392
Haverford Financial Services
Pennsylvania
$7.51M +$240K +4,022 +3%
OA
393
OFI Advisors
Pennsylvania
$7.47M +$305K +5,122 +4%
B
394
BP
United Kingdom
$7.38M -$1.19M -20,000 -13%
LIM
395
Lathrop Investment Management
Arkansas
$7.34M +$137K +2,295 +2%
CIC
396
Chase Investment Counsel
Virginia
$7.34M -$2.38M -39,970 -24%
MA
397
MUFG Americas
New York
$7.27M +$902K +15,130 +13%
AP
398
Atwood & Palmer
Missouri
$7.25M +$50.2K +842 +0.7%
Citadel Advisors
399
Citadel Advisors
Florida
$7.24M -$49.9M -837,498 -87%
MBE
400
Michael B. Elefante
$7.2M -$301K -5,045 -4%

CVS Hedge Fund Activity: Q3 2013 in Review

1,130 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2013, worth a combined $58.3B — down 2.2% from $59.6B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CVS positions and 50 closed out — a net gain of 36 holders — while 440 added to existing stakes and 470 trimmed.

The largest buyer was abrdn Investment Management, adding an estimated $166M. The largest seller was Fidelity Investments, cutting an estimated $270M.

  • 1,130 institutional investors held CVS Health (CVS) as of Q3 2013, up from 1,107 in Q2 2013.
  • Funds reported $58.3B of CVS Health stock for Q3 2013, down 2.2% quarter-over-quarter.
  • 86 funds opened new CVS Health positions in Q3 2013 and 50 closed out, a net change of +36 holders.
  • The largest CVS Health buyer in Q3 2013 was abrdn Investment Management, an estimated $166M added.
  • The largest CVS Health seller in Q3 2013 was Fidelity Investments, an estimated $270M sold.

Based on aggregated 13F filings for Q3 2013.